Threshold Pharma (THLD) – All Earnings Related News
-
Threshold Pharma (THLD) to Discontinue Tarloxotinib Development; Will Refocus Resources
-
Threshold Pharma (THLD) Reports Q2 Loss of $0.10/Share
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to THLD Stock Lookup